Johns Hopkins researchers have found a significant rise in serious complications requiring hospitalization following prostate biopsy among Medicare beneficiaries, according to a Johns Hopkins news release.
The researchers found that this common outpatient procedure, used to diagnose prostate cancer, was associated with a 6.9 percent rate of hospitalization within 30 days of biopsy compared to a 2.9 percent hospitalization rate among a control group of men who did not have a prostate biopsy. Those hospitalized had a range of complications, such as bleeding and infection, as well as flare-ups of underlying medical conditions, such as heart failure or breathing disorders.
The researchers emphasize that this new data should serve as a reminder to physicians to carefully weigh the risks and benefits of biopsy for individual patients and take all precautions to prevent infections and other complications.
10 Proven Ways to Reduce Hospital Readmissions
Infection Rates Among New York Hospitals Falling
The researchers found that this common outpatient procedure, used to diagnose prostate cancer, was associated with a 6.9 percent rate of hospitalization within 30 days of biopsy compared to a 2.9 percent hospitalization rate among a control group of men who did not have a prostate biopsy. Those hospitalized had a range of complications, such as bleeding and infection, as well as flare-ups of underlying medical conditions, such as heart failure or breathing disorders.
The researchers emphasize that this new data should serve as a reminder to physicians to carefully weigh the risks and benefits of biopsy for individual patients and take all precautions to prevent infections and other complications.
Related Articles on Quality:
AHRQ Initiative Aims to Foster Better Communication Between Clinicians and Patients10 Proven Ways to Reduce Hospital Readmissions
Infection Rates Among New York Hospitals Falling